- Country: Germany
- Summary: Generika Tender 5004 - Rivaroxaban
- DET Ref No: 127671803
- Deadline: 07 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 656916-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Completion of pharmaceutical discounts according to Section 130a (8) SGB V for the active ingredient rivaroxaban (B01AF01)
Exclusive pharmaceutical discount contracts according to § 130a
Contract partners.
Information can be found in the tender documents
Generika tender 5004 - Rivaroxaban
supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINGenerika Tender 5004 - Rivaroxaban - Germany Tender
The SPECTRUMK GMBH, a Government sector organization in Germany, has announced a new tender for Generika Tender 5004 - Rivaroxaban. This tender is published on GermanyTenders under DET Ref No: 127671803 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
